Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
9 pending office actions • 6 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (11%) |
| §102 only | 1 (11%) |
| §112 only | 5 (56%) |
| Multi-statute (no §101) | 2 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAMSELL, RILLA MARIE | 1 | 70.8% | +4.6% |
| MCDOWELL, BRIAN E | 1 | 74.1% | +30.8% |
| SEITZ, ANTHONY JOSEPH | 1 | 68.3% | +27.0% |
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
| RAO, SAVITHA M | 1 | 60.7% | +30.2% |
| SANCHEZ, JUSTIN CHRISTOPHER | 1 | 88.7% | +10.2% |
| CHEN, PO-CHIH | 1 | 74.2% | +14.8% |
| BURKETT, DANIEL JOHN | 1 | 62.6% | +33.2% |
| BRAUN, MADELINE E | 1 | 68.0% | +25.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17597631 | PROTEIN DEGRADERS AND USES THEREOF | SANCHEZ, JUSTIN CHRISTOPHER | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18453163 | CDK2 INHIBITORS AND USES THEREOF | SEITZ, ANTHONY JOSEPH | 8d overdue |
| 18583347 | CRBN LIGANDS AND USES THEREOF | MCDOWELL, BRIAN E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17597166 | IRAK DEGRADERS AND USES THEREOF | BURKETT, DANIEL JOHN | 164d overdue |
| 18453163 | CDK2 INHIBITORS AND USES THEREOF | SEITZ, ANTHONY JOSEPH | 8d overdue |
| 18583347 | CRBN LIGANDS AND USES THEREOF | MCDOWELL, BRIAN E | — |
| 18453156 | CDK2 DEGRADERS AND USES THEREOF | GONZALEZ, LUISALBERTO | — |
| 18002116 | IRAK DEGRADERS AND USES THEREOF | RAO, SAVITHA M | — |
| 17597631 | PROTEIN DEGRADERS AND USES THEREOF | SANCHEZ, JUSTIN CHRISTOPHER | — |
| 17597628 | FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF | CHEN, PO-CHIH | — |
| 17596486 | SMARCA DEGRADERS AND USES THEREOF | BRAUN, MADELINE E | — |
| Art Unit | Apps |
|---|---|
| 1624 | 4 |
| 1629 | 1 |
| 1691 | 1 |
| 1622 | 1 |
| 1621 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18704633 | TYK2 DEGRADERS AND USES THEREOF | SAMSELL, RILLA MARIE | 1624 | §112 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18583347 | CRBN LIGANDS AND USES THEREOF | MCDOWELL, BRIAN E | 1624 | §102§112 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18453163 | CDK2 INHIBITORS AND USES THEREOF | SEITZ, ANTHONY JOSEPH | 1629 | §102§103§112 | Final Rejection | 8d overdue | Pending | Aug 21, 2023 |
| 18453156 | CDK2 DEGRADERS AND USES THEREOF | GONZALEZ, LUISALBERTO | 1624 | §112 | Non-Final OA | — | Pending | Aug 21, 2023 |
| 18002116 | IRAK DEGRADERS AND USES THEREOF | RAO, SAVITHA M | 1691 | §112 | Non-Final OA | — | Pending | Dec 16, 2022 |
| 17597631 | PROTEIN DEGRADERS AND USES THEREOF | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §112 | Final Rejection | — | Pending | Jan 14, 2022 |
| 17597628 | FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF | CHEN, PO-CHIH | 1621 | §102 | Final Rejection | — | Pending | Jan 14, 2022 |
| 17597166 | IRAK DEGRADERS AND USES THEREOF | BURKETT, DANIEL JOHN | 1624 | §103 | Final Rejection | 164d overdue | Pending | Dec 28, 2021 |
| 17596486 | SMARCA DEGRADERS AND USES THEREOF | BRAUN, MADELINE E | 1626 | §112 | Non-Final OA | — | Pending | Dec 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial